Skip to content

Dr. Gaurav Kharya

Dr. Gaurav Kharya

  • Position: Senior Consultant – Paediatric Oncology & Haematology
  • Affiliation: Clinical Lead at Centre for BMT (Bone Marrow Transplant) & CT (Cellular Therapy), Senior Consultant Paediatric Haematology Oncology & Immunology at Indraprastha Apollo Hospital Delhi

Training and Expertise:

  • Dr. Kharya has received training both in India and abroad.
  • Specializes in a wide range of Paediatric blood disorders, cancers, and bone marrow transplant procedures.

Achievements:

  • Credited for conducting the largest number of transplants for Sickle Cell Disease in the country.
  • Developed innovative protocols for various transplant procedures.

Academic and Research Interests:

  • Dr. Kharya has a keen interest in academics and research.
  • Focuses on futuristic therapies, including Chimeric Antigen Receptor T Cell therapy.
  • Researches Gene Editing/Gene Therapy for various inborn errors.

Dr. Gaurav Kharya is a distinguished figure in the field of Paediatric Oncology & Haematology, serving as a Clinical Lead at the Centre for BMT and CT while holding the position of Senior Consultant in Paediatric Haematology Oncology & Immunology at Indraprastha Apollo Hospital Delhi. His extensive training, both in India and abroad, has equipped him with expertise in treating a broad spectrum of Paediatric blood disorders, cancers, and bone marrow transplant procedures.

One of Dr. Kharya’s notable accomplishments is his credit for performing the largest number of transplants for Sickle Cell Disease in the country. His contributions also extend to the development of innovative protocols for various transplant procedures, enhancing the field’s treatment options.

In addition to his clinical work, Dr. Kharya is deeply involved in academics and research. He places special emphasis on pioneering therapies like Chimeric Antigen Receptor T Cell therapy, which holds promise for the future of cancer treatment. Furthermore, he is actively engaged in researching Gene Editing and Gene Therapy techniques, especially for addressing various inborn errors in patients.

Dr. Gaurav Kharya’s commitment to advancing medical knowledge and providing cutting-edge treatments underscores his dedication to improving the lives of children with complex blood disorders and cancers.